McKesson Corporation $MCK Stock Holdings Increased by HF Advisory Group LLC

HF Advisory Group LLC increased its stake in shares of McKesson Corporation (NYSE:MCK) by 2,069.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,910 shares of the company’s stock after purchasing an additional 42,840 shares during the quarter. McKesson makes up approximately 1.4% of HF Advisory Group LLC’s holdings, making the stock its 10th largest holding. HF Advisory Group LLC’s holdings in McKesson were worth $36,839,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the company. GGM Financials LLC purchased a new stake in shares of McKesson during the third quarter worth about $25,000. State of Wyoming purchased a new position in shares of McKesson during the second quarter valued at approximately $29,000. Hopwood Financial Services Inc. acquired a new stake in McKesson during the third quarter worth approximately $31,000. Vermillion & White Wealth Management Group LLC acquired a new stake in McKesson during the third quarter worth approximately $33,000. Finally, Board of the Pension Protection Fund purchased a new stake in McKesson in the 4th quarter worth approximately $33,000. Institutional investors and hedge funds own 85.07% of the company’s stock.

McKesson Stock Up 0.9%

NYSE:MCK opened at $873.50 on Thursday. The company has a market cap of $106.99 billion, a P/E ratio of 25.12, a P/E/G ratio of 1.39 and a beta of 0.38. The firm’s 50 day moving average is $909.89 and its two-hundred day moving average is $842.98. McKesson Corporation has a fifty-two week low of $637.00 and a fifty-two week high of $999.00.

McKesson (NYSE:MCK) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.19 by $0.15. The company had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The business’s quarterly revenue was up 11.4% compared to the same quarter last year. During the same period in the previous year, the company earned $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Research analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd were paid a $0.82 dividend. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend was Monday, March 2nd. McKesson’s payout ratio is currently 9.43%.

Insider Buying and Selling at McKesson

In other news, Director Maria Martinez sold 349 shares of the stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $939.87, for a total value of $328,014.63. Following the completion of the sale, the director owned 301 shares of the company’s stock, valued at $282,900.87. This represents a 53.69% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Thomas L. Rodgers sold 276 shares of the stock in a transaction on Monday, January 5th. The stock was sold at an average price of $816.18, for a total transaction of $225,265.68. Following the completion of the sale, the executive vice president directly owned 2,268 shares of the company’s stock, valued at $1,851,096.24. The trade was a 10.85% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 3,868 shares of company stock worth $3,743,820. Company insiders own 0.08% of the company’s stock.

Analysts Set New Price Targets

Several research firms have commented on MCK. Evercore reaffirmed an “outperform” rating on shares of McKesson in a research note on Thursday, March 5th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of McKesson in a report on Wednesday, December 10th. Wells Fargo & Company lifted their price objective on McKesson from $914.00 to $925.00 and gave the company an “equal weight” rating in a research report on Thursday, February 5th. Morgan Stanley reiterated an “overweight” rating and issued a $966.00 target price on shares of McKesson in a research note on Thursday, January 29th. Finally, Mizuho raised their price target on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Thirteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, McKesson has a consensus rating of “Moderate Buy” and a consensus target price of $960.93.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.